Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT. Guo W, Zhang H, Zheng Y, Gao H, et al. Ann Hematol 2024;103:3155-3163.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guo W, Zhang H, Zheng Y, Gao H, et al. Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT. Ann Hematol 2024;103:3155-3163.
PMID: 38907755